Onyx Biotec

Onyx Biotec

42.80
+0.80
(1.90%)
hide
Key Fundamentals
Add Ratio
Market Cap
76.20 Cr
EPS
3.31
PE Ratio
15.68
Dividend Yield
0.00 %
Industry
Healthcare
52 Week High
97.45
52 Week Low
35.50
PB Ratio
1.40
Debt to Equity
0.53
Forecast For
Actual

Company News

View All News
Caret
neutral
Onyx Biotec: Weak Market Debut with 11.5% Discount on ListingNov 22, 2024
Onyx Biotec listed at ₹54 on NSE SME, 11.5% below its IPO price of ₹61. The stock recovered slightly post-listing to ₹56.75. The ₹29.34 crore IPO was oversubscribed 198 times. Proceeds will be used for manufacturing upgrades, loan repayment, and corporate purposes.
Competitors
LTP
Market Cap (₹ Cr.)
P/E Ratio
Revenue (₹ Cr.)
YoY Revenue Growth %
Net Profit (₹ Cr.)
YoY Profit Growth %
RSI
1,732.10
#1 4,11,749.90
39.63
#1 54,729.00
9.71
#1 10,980
2.89
66.26
6,520.00
1,73,603.20
69.64
9,712.00
18.67
2,191
35.10
50.59
3,824.60
1,29,482.50
60.46
11,539.40
6.99
1,911
30.46
70.50
1,519.30
1,22,366.70
22.59
28,409.50
7.12
5,291
3.71
44.46
1,229.60
1,01,113.50
#1 17.88
33,741.20
16.73
5,725
-0.38
47.35
951.40
94,475.30
19.03
23,511.00
18.55
4,615
34.60
39.39
2,270.00
91,653.00
52.89
12,744.20
#1 20.90
2,007
-21.05
32.59
2,033.90
90,250.10
21.39
22,909.50
13.74
3,306
#1 72.75
62.84
5,767.50
68,110.20
29.54
13,458.30
3.70
2,216
21.39
70.49
1,183.60
67,849.20
20.35
32,345.60
9.43
3,484
3.81
67.18
Growth Rate
Revenue Growth
17.07 %
Net Income Growth
38.89 %
Cash Flow Change
-6.58 %
ROE
-38.00 %
ROCE
1.02 %
EBITDA Margin (Avg.)
16.10 %

Yearly Financial Results

Annual Financials
2022
2023
2024
2025
TTM
Revenue
45
40
54
63
0
Expenses
39
35
45
52
0
EBITDA
6
5
9
12
0
Operating Profit %
13 %
11 %
16 %
17 %
0 %
Depreciation
1
2
2
3
0
Interest
1
1
2
2
0
Profit Before Tax
4
3
5
7
0
Tax
0
1
1
2
0
Net Profit
3
2
4
5
0
EPS in ₹
2.84
1.56
3.05
3.31
0.00

Balance Sheet

Balance Sheet
2022
2023
2024
2025
Total Assets
37
59
74
91
Fixed Assets
17
43
44
41
Current Assets
14
15
30
49
Capital Work in Progress
4
0
0
0
Investments
0
0
0
0
Other Assets
16
16
31
50
Total Liabilities
37
59
74
91
Current Liabilities
10
20
23
26
Non Current Liabilities
10
20
26
10
Total Equity
16
18
25
56
Reserve & Surplus
11
12
12
38
Share Capital
6
6
13
18

Cash Flow

Cash Flow
2022
2023
2024
2025
Net Cash Flow
-0
-4
2
7
Investing Activities
-6
-23
-3
1
Operating Activities
1
2
2
1
Financing Activities
5
16
3
5

Share Holding

% Holding
Nov 2024
Mar 2025
Sept 2025
Promoter
65.10 %
65.10 %
65.10 %
FIIs
0.00 %
0.00 %
0.00 %
DIIs
0.03 %
0.00 %
0.00 %
Government
0.00 %
0.00 %
0.00 %
Public / Retail
18.96 %
18.97 %
22.64 %
Others
15.92 %
15.94 %
12.27 %
No of Share Holders
1,181
551
640

Corporate Action

Record Date Corporate Action Information Announcement Day LTP at Annoucement LTP at Record Day
13 Nov 2025 QUARTERLY RESULT ANNOUNCEMENT Quarterly Result Announcement
NA
13 Nov 2025 39.00 42.80
10 Jan 2025 QUARTERLY RESULT ANNOUNCEMENT Quarterly Result Announcement
NA
10 Jan 2025 90.15 78.95
28 May 2025 QUARTERLY RESULT ANNOUNCEMENT Quarterly Result Announcement
NA
28 May 2025 49.25 49.90

Technical Indicators

RSI(14)
Neutral
50.38
ATR(14)
Less Volatile
2.14
STOCH(9,6)
Neutral
56.42
STOCH RSI(14)
Overbought
84.82
MACD(12,26)
Bullish
0.29
ADX(14)
Strong Trend
41.84
UO(9)
Bearish
74.85
ROC(12)
Downtrend And Accelerating
-5.19
WillR(14)
Neutral
-32.16